Altimmune, Inc. SC 13G and SC 13G/A reports

Location
910 Clopper Road, Suite 201 S, Gaithersburg, MD
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/12/2024, 04:09 PM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Oct 17, 2024
SC 13G/A Report Oct 16, 2024
SC 13G/A Report Jul 10, 2024
SC 13G/A Report Apr 10, 2024
SC 13G Report Mar 5, 2024
SC 13G/A Report AMENDMENT NO. 2 Feb 14, 2024
SC 13G/A Report Feb 14, 2024
SC 13G/A Report Feb 14, 2024
SC 13G/A Report Feb 14, 2024
SC 13G Report SC 13G Feb 14, 2024
SC 13G/A Report Feb 14, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 13, 2024
SC 13G/A Report JHG OWNS <5% Feb 12, 2024
SC 13G Report Jan 26, 2024
SC 13G/A Report Jan 23, 2024
SC 13G/A Report Jul 10, 2023
SC 13G/A Report Apr 12, 2023
SC 13G/A Report AMENDMENT NO. 1 Feb 14, 2023
SC 13G/A Report Feb 14, 2023
SC 13G/A Report Feb 14, 2023
SC 13G/A Report Feb 14, 2023
SC 13G Report JHG PLC OWNS >5% Feb 13, 2023
SC 13G Report SCHEDULE 13G Feb 9, 2023
SC 13G/A Report Jan 10, 2023
SC 13G Report Jul 8, 2022
SC 13G Report Jul 7, 2022
SC 13G/A Report Apr 11, 2022
SC 13G Report Mar 24, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G Report Feb 11, 2022
SC 13G Report Feb 11, 2022
SC 13G/A Report Feb 11, 2022
SC 13G Report Feb 4, 2022
SC 13G Report Jan 3, 2022
SC 13G Report Sep 10, 2021
SC 13G Report SC 13G Aug 31, 2021
SC 13G Report SCHEDULE 13G Mar 1, 2021
SC 13G/A Report VELOCITY PHARMACEUTICAL HOLDINGS LLC SCHEDULE 13 G/A Feb 16, 2021
SC 13G Report SCHEDULE 13G Feb 16, 2021
SC 13G/A Report SC 13G/A Feb 16, 2021
SC 13G/A Report ALT 13GA Feb 8, 2021
SC 13G Report SC 13G Oct 5, 2020
SC 13G Report SC 13G Sep 24, 2020
SC 13G Report SC 13G Jun 1, 2020
SC 13G Report VELOCITY PHARMACEUTICAL HOLDINGS 13G Feb 14, 2020
SC 13G/A Report AMENDMENT NO. 2 TO SCHEDULE 13G Feb 11, 2020
SC 13G/A Report ALT 13GA Jan 31, 2020
SC 13G/A Report SC 13G/A Feb 14, 2019
SC 13G/A Report SC 13G/A Feb 11, 2019
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Feb 8, 2019
SC 13G/A Report SC 13G/A Feb 5, 2019
SC 13G/A Report ALT 13GA Feb 1, 2019
SC 13G Report SCHEDULE 13G Oct 17, 2018
SC 13G Report SC 13G Oct 5, 2018
SC 13G/A Report SC 13G/A Oct 4, 2018
SC 13G/A Report Feb 14, 2018
SC 13G/A Report SC 13G/A Feb 12, 2018
SC 13G/A Report SC 13G/A Feb 9, 2018
SC 13G/A Report SC 13G/A Feb 2, 2018
SC 13G Report ALTIMMUNE, INC. SC13G Feb 2, 2018
SC 13G/A Report SC 13G/A Aug 23, 2017
SC 13G Report SC 13G May 15, 2017
SC 13G Report SC 13G May 15, 2017
SC 13G Report SC 13G May 8, 2017
SC 13G/A Report SC 13G/A Feb 14, 2017
SC 13G Report 13G Feb 14, 2017
SC 13G/A Report SC 13G/A Feb 10, 2017
SC 13G Report SCHEDULE 13G Oct 19, 2016
SC 13G/A Report SCHEDULE 13G/A Feb 16, 2016
SC 13G/A Report SC 13G/A Feb 17, 2015
SC 13G/A Report Aug 18, 2014
SC 13G Report SC 13G Apr 2, 2014
SC 13G/A Report AMENDMENT TO FORM SC 13G Oct 5, 2011
SC 13G/A Report SC 13G/A Feb 14, 2011
SC 13G Report Jan 31, 2011
SC 13G Report Jan 31, 2011
SC 13G/A Report PHARMATHENE, INC. Jan 18, 2011
SC 13G Report PHARMATHENE, INC. Jul 30, 2010
SC 13G Report EMPERY ASSET MANAGEMENT, LP/PHARMATHENE, INC. Apr 19, 2010
SC 13G/A Report Feb 16, 2010
SC 13G Report Feb 10, 2010